Biotech Medics Ne
BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrat… Read more
Biotech Medics Ne (BMCS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.001x
Based on the latest financial reports, Biotech Medics Ne (BMCS) has a cash flow conversion efficiency ratio of 0.001x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($52.11K) by net assets ($99.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biotech Medics Ne - Cash Flow Conversion Efficiency Trend (2008–2023)
This chart illustrates how Biotech Medics Ne's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biotech Medics Ne Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biotech Medics Ne ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MALACHITE RESOURCES
BE:MUW
|
N/A |
|
Real Estate Credit Investments Limited
LSE:RECI
|
-0.049x |
|
PREMIER PAINTS PLC
XNSA:PREMPAINTS
|
N/A |
|
UMC Inc
PINK:UMCN
|
-1.613x |
|
Baker Steel Resources Trust
LSE:BSRT
|
-0.005x |
|
Puma VCT 13 PLC
LSE:PU13
|
-0.006x |
|
AHLERS - Dusseldorf Stock Exchang
DU:AAH
|
N/A |
|
Aeon Ventures Inc
PINK:IDEA
|
-0.105x |
Annual Cash Flow Conversion Efficiency for Biotech Medics Ne (2008–2023)
The table below shows the annual cash flow conversion efficiency of Biotech Medics Ne from 2008 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $99.57 Million | $-26.90K | 0.000x | -12.05% |
| 2022-12-31 | $69.58 Million | $-16.77K | 0.000x | +90.77% |
| 2021-12-31 | $69.67 Million | $-182.03K | -0.003x | -101.65% |
| 2020-12-31 | $-186.78K | $-29.62K | 0.159x | -99.32% |
| 2016-12-31 | $-43.28K | $-1.01 Million | 23.366x | +2034.80% |
| 2015-12-31 | $968.05K | $-1.17 Million | -1.208x | -- |
| 2011-12-31 | $3.06 Million | $0.00 | 0.000x | -- |
| 2008-12-31 | $1.06 Million | $0.00 | 0.000x | -- |